LIVER DISEASE

Fatigue is associated with high circulating leptin levels in chronic hepatitis C

T Piche¹, E Gelsi¹, S M Schneider¹, X Hébuterne¹, J Giudicelli², B Ferrua², C Laffont³, S Benzaken⁴, P Hastier¹, M L Montoya¹, F Longo¹, P Rampal¹, A Tran¹

¹ Department of Hepatogastroenterology and Nutrition, CHU de NICE, France
² Department of Biochemistry, CHU de NICE, France
³ Department of Virology, CHU de NICE, France
⁴ Department of Immunology, CHU de NICE, France

Correspondence to:
Correspondence to:
Dr T Piche, Hôpital de l'Archet 2, HépatoGastroenterologie et Nutrition, BP 3079, 06202 NICE Cedex 3, France;
tpiche{at}fc.horus-medical.fr

Background and aims: Fatigue is a frequent and disabling symptom reported by patients with chronic hepatitis C (CHC). Its mechanism is poorly understood. Recent attention has focused on the role of leptin and energy expenditure in CHC. Our aims were to analyse fatigue in CHC and to determine its relationship with disease activity, resting energy expenditure (REE), circulating leptin, and tumour necrosis factor (TNF-).

Methods: Seventy eight CHC patients, 22 healthy controls, and 13 primary biliary cirrhosis (PBC) patients underwent measurements of REE, body composition, leptin, and TNF-. All subjects completed the fatigue impact scale (FIS) questionnaire. A liver biopsy and viral load measurements were performed in all patients.

Results: Thirty eight of 78 CHC patients considered fatigue the worst or initial symptom of their disease. The fatigue score of patients was significantly higher than that of controls (53.2 (40.1) v 17.7 (16.9); p<0.0001) and was more pronounced in females (p=0.003). Leptin was increased significantly in CHC patients compared with controls (15.4 (20.7) v 6.4 (4.1) ng/ml; p<0.05). In CHC patients, the fatigue score correlated significantly with leptin corrected for fat mass (r=0.30, p=0.01). This correlation increased when the physical domain of fatigue was included (r=0.39, p=0.0009). Furthermore, a similar positive correlation was found in PBC patients (r=0.56, p=0.04). No correlation was found between fatigue and age, REE, liver function tests, viral load, or the METAVIR score in CHC patients.

Conclusions: Fatigue is present in CHC patients and is more pronounced in females. The FIS questionnaire is clinically relevant and may be useful for future therapeutic trials aimed at reducing fatigue. Fatigue may be partly mediated by leptin.

Keywords: fatigue; chronic hepatitis C; leptin

Abbreviations: CHC, chronic hepatitis C; FIS, fatigue impact scale; REE, resting energy expenditure; FM, fat mass; FFM, fat free mass; TNF-, tumour necrosis factor ; ALT, alanine aminotransferase; BMI, body mass index; HCV, hepatitis C virus; PBC, primary biliary cirrhosis

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Article

Digest

Ian Forgacs
Gut 2002 51: 301. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Seaman, K., Paterson, B. L., Vallis, M., Hirsch, G., Peltekian, K. M. (2009). Future directions for investigation of fatigue in chronic hepatitis C viral infection. Chronic Illness 5: 115-128 [Abstract]  
• Piche, T, Saint-Paul, M C, Dainese, R, Marine-Barjoan, E, Iannelli, A, Montoya, M L, Peyron, J F, Czerucka, D, Cherikh, F, Filippi, J, Tran, A, Hebuterne, X (2008). Mast cells and cellularity of the colonic mucosa correlated with fatigue and depression in irritable bowel syndrome. Gut 57: 468-473 [Abstract] [Full Text]  
• Bloomgarden, Z. T. (2006). Aspects of type 2 diabetes and related insulin-resistant States.. Diabetes Care 29: 732-740 [Full Text]  
• Piche, T, Vanbiervliet, G, Cherikh, F, Antoun, Z, Huet, P M, Gelsi, E, Demarquay, J-F, Caroli-Bosc, F-X, Benzaken, S, Rigault, M-C, Renou, C, Rampal, P, Tran, A (2005). Effect of ondansetron, a 5-HT3 receptor antagonist, on fatigue in chronic hepatitis C: a randomised, double blind, placebo controlled study. Gut 54: 1169-1173 [Abstract] [Full Text]